Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Safety Study of LY2886721 Multiple Doses in Healthy Subjects [Phase 1]
Phase 1 safety study of LY2886721 with multiple doses in healthy subjects completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia [Phase 3]
Phase 3 study of lanabecestat (LY3314814) in early Alzheimer's disease dementia was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) [Phase 2]
Phase 2 trial investigating levetiracetam for neuropsychiatric symptoms related to epilepsy in Alzheimer's disease patients; status not spec…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Caring for the Caregiver Network [NA]
Clinical trial update for a caregiver support network study; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD) [Phase 2]
Phase 2 clinical trial evaluating p38 MAP kinase inhibitor VX-745 on amyloid plaque load in Alzheimer's disease and mild cognitive impairmen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Evaluating Liraglutide in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating liraglutide for Alzheimer's disease is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants [Phase 1]
Phase 1 trial update for TAK-071 includes healthy participants and those with mild cognitive impairment/mild Alzheimer disease; study termin…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease [Phase 2]
A Phase 2 dose-finding study evaluated the efficacy and safety of ID1201 in patients with mild Alzheimer's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. [Phase 1]
Phase 1 trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of MEDI1814 in mild-to-moderate Alzheimer's disease pati…
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: Application of Amyloid PET in Cerebral Amyloid Angiopathy [Phase 3]
Phase 3 trial investigating the use of amyloid PET imaging in cerebral amyloid angiopathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) [Phase 3]
Phase 3 trial of verubecestat (MK-8931) in prodromal Alzheimer's disease and amnestic MCI was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease [Phase 2]
Phase 2 trial investigating intravenous immunoglobulin (IVIG) for cerebral and retinal amyloid in mild cognitive impairment due to Alzheimer…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging [Phase 4]
Phase 4 clinical trial update investigating early diagnosis and early treatment of Alzheimer's disease using senile plaque imaging.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE) [Phase 2]
Phase 2 study investigating pimavanserin for agitation and aggression in Alzheimer's disease; the trial was terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer [Phase 4]
Phase 4 clinical trial comparing once daily versus twice daily memantine for safety and tolerability in Alzheimer dementia; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Escitalopram Effects on CSF Amyloid Beta [Phase 4]
A Phase 4 clinical trial evaluated escitalopram's effects on cerebrospinal fluid amyloid beta levels; results have been posted after complet…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001) [Phase 1]
Phase 1 PET tracer validation trial for [11C]MK-6884 in Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline [NA]
Completed feasibility trial evaluating a Mediterranean diet pattern to prevent cognitive decline in individuals with Alzheimer's disease or …
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
A completed clinical trial sponsored by the University of Pennsylvania evaluated care coordination from hospital to home for cognitively imp…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia [Phase 1]
A Phase 1 study evaluating the effects of JNJ-54861911 on amyloid-beta processing in cerebrospinal fluid and plasma in Japanese participants…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
A completed Duke University clinical trial evaluating novel retinal imaging biomarkers for detecting early Alzheimer's disease and related c…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Indiana University Dementia Screening Trial [NA]
Indiana University’s Dementia Screening Trial (NCT01699503) has completed and posted results for dementia/Alzheimer’s disease screening, inc…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Triggered Palliative Care for Advanced Dementia [NA]
Clinical trial update for triggered palliative care in advanced dementia shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-02Clinical Trial Update: Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of AD-35 Tablet in patients with Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Side Effects of Newer Antipsychotics in Older Adults [Phase 4]
Phase 4 clinical trial update examining side effects of newer antipsychotics in older adults.